Not content to just put out one twisty movie at the holiday season with Wake Up Dead Man, Netflix decided to open the floodgates – pun fully intended – with South Korean disaster movie The Great Flood ...

Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal films, but audiences are divided over its cryptic ending and philosophical twist ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The first season of HBO's It: Welcome to Derry has come to a close, leaving us with a long list of questions that need to somehow be answered when the show leaps back in time another 27 years for ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: HBO Well, that was ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Claire Danes and Matthew Rhys, our jaws are on the floor at that wild and tumultuous finale of The Beast in Me. **Spoilers ahead for the Season 1 finale, now streaming on Netflix** While we as the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...